The genomic complexity of primary human prostate cancer - Test2 - elhamkhani - TriplyDB

The genomic complexity of primary human prostate cancer

The genomic complexity of primary human prostate cancer

http://www.wikidata.org/entity/Q24617949

about

GROM-RD: resolving genomic biases to improve read depth detection of copy number variants Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer Integrative annotation of variants from 1092 humans: application to cancer genomics SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes Melanoma genome sequencing reveals frequent PREX2 mutations Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer Network of Cancer Genes (NCG 3.0): integration and analysis of genetic and network properties of cancer genes Mutational processes molding the genomes of 21 breast cancers Genome sequencing identifies a basis for everolimus sensitivity The genomic and transcriptomic landscape of a HeLa cell line Cullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic Implications Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas Epigenetic modulators, modifiers and mediators in cancer aetiology and progression The structure and function of NKAIN2-a candidate tumor suppressor Molecular Process Producing Oncogene Fusion in Lung Cancer Cells by Illegitimate Repair of DNA Double-Strand Breaks The path to routine use of genomic biomarkers in the cancer clinic Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications Mutational signatures: the patterns of somatic mutations hidden in cancer genomes Recurrent rearrangements in prostate cancer: causes and therapeutic potential The mutational landscape of prostate cancer Genomic sequencing in cancer Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer Systems biology of cisplatin resistance: past, present and future Computational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challenges How many molecular subtypes? Implications of the unique tumor principle in personalized medicine Genome sequencing and cancer Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies Quo vadis: advanced prostate cancer-clinical care and clinical research in the era of multiple androgen receptor-directed therapies Emerging patterns of somatic mutations in cancer Evolution of the cancer genome Interplay between genomic alterations and androgen receptor signaling during prostate cancer development and progression Current evidence linking polyunsaturated Fatty acids with cancer risk and progression Pediatric solid tumor genomics and developmental pliancy Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.Integrative clinical genomics of advanced prostate cancer.Noncanonical views of homology-directed DNA repair Comprehensive genomic characterization of squamous cell lung cancers.

P2860

Q21128696-2BA5EC32-0B05-41D0-8BB0-E05487C0FDD1 Q21131727-31C69873-93E4-43DE-8846-61D65D9FBAFD Q21184064-A405F17D-3CA5-4DBC-91A5-794A61832EB0 Q22065599-0DAB7DAA-328C-40B9-8329-E2B16445DDE1 Q24339492-3DA81BF6-F1E6-4640-B139-996E3E81F878 Q24596715-454B8C40-7DBF-428E-8098-C9D1554461A6 Q24610463-FBA35FE8-C71F-4BCC-93A6-2351667FCE8A Q24616117-272172E1-BABC-42F8-8795-9EB3D8E2EFF0 Q24619351-456A8E6E-3624-4A48-8F34-3A3E2D92F76C Q24620915-122E077A-7472-40C8-BCD7-E7BA7520412A Q24631915-DC41B751-B157-4CC2-8E99-E205EF069C77 Q24632989-AD73488B-47A9-449B-ABB3-8AE62E03944A Q26747274-5A7BFDDC-D1DD-49AE-BE32-52CB431ADD43 Q26751724-958AB65F-033D-46A0-8945-A46AB6F8832C Q26766149-942251A4-58CE-44FD-9109-5AEFBCB9B7D6 Q26771844-547FDE06-4CF1-4E8B-BB99-C97B759A52C7 Q26781994-DEF3E36A-C028-4930-AAF5-0394B7795197 Q26782733-D6EFE8AF-66F3-45BB-B51F-6806646EF42A Q26797063-D587FB28-3728-4A49-8609-8F733EF3808B Q26850125-450DB399-D0E6-46C5-9707-943CD6D342C5 Q26851525-659B3068-8B96-4F83-9C1A-9BB6C3EA54F0 Q26851631-EF22FF72-40F0-4F8A-9D0F-3F8D18CA0272 Q26853507-709B74BC-EF45-4A01-AF85-4E860FF58A43 Q26858922-2C8A94CE-1ECE-4AD0-9C64-80E7D89ECB4F Q26863585-BCB8D8A7-DF78-492D-A942-4284E27880AA Q26864808-697DB55F-86AE-4E9E-98AD-7BCB388943A1 Q26992045-AAB18472-6FB0-4817-A22C-ABB0925A02A9 Q26998499-30E4D9AF-6B81-45FE-A35A-EDDA223B2FC5 Q27007065-FF3C71B2-642D-4387-8168-9AD31A9EB5F9 Q27011642-80116B5A-F460-466B-B0BC-53E16DDD9EBF Q27014126-858BF7E5-F68B-44F7-A769-9DEA9D09CFC6 Q27020991-0EC26CC4-1FF2-429A-BDB8-13890CCB40DB Q27022288-FE08532B-E7CA-4819-A7FB-27EABA1943AB Q27022573-E9C7326F-96DE-40C5-AAE3-04852443A1AE Q27023560-84A7A80C-4628-482B-86A4-75A0587C86F3 Q27024626-F00AD96D-6F37-43C6-8513-D6D9CF5853BA Q27690285-A39B852A-ED66-42E0-B8ED-94B54AD8883A Q27853170-812B3741-C2DC-4CCF-9400-A2475BD12A99 Q28080032-5CBF9758-C261-4AE2-93CD-3F5F7AAC4EEE Q28274701-963E006B-F95F-4BEF-8CD0-14F9AA0C9ABB

P2860

The genomic complexity of primary human prostate cancer

http://www.wikidata.org/entity/Q24617949

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The genomic complexity of primary human prostate cancer

@ast

The genomic complexity of primary human prostate cancer

@en

The genomic complexity of primary human prostate cancer

@nl

type

label

The genomic complexity of primary human prostate cancer

@ast

The genomic complexity of primary human prostate cancer

@en

The genomic complexity of primary human prostate cancer

@nl

prefLabel

The genomic complexity of primary human prostate cancer

@ast

The genomic complexity of primary human prostate cancer

@en

The genomic complexity of primary human prostate cancer

@nl

P1433

Q24617949-52648305-F5CD-4659-9E6F-E53C480B2848

P1476

Q24617949-BB778F8E-CA35-4B6B-8326-72DDF6EE27AC

P2093

Q24617949-014AF70F-0C1A-4AE4-99CA-A6E909603BA7

Q24617949-0D7357C8-8095-468A-950F-45B91AD9B43A

Q24617949-21A18406-FDC8-4712-A5ED-4040EC2A36F4

Q24617949-511687C3-25F6-42BA-B5FB-81EA72222705

Q24617949-5357370B-CAD3-4563-87EA-45E49F3228F6

Q24617949-5735640D-A418-4F52-AB60-CF703DA26282

Q24617949-57A6E708-53D5-461E-A896-E007CB8ADAF3

Q24617949-621B0B60-1249-4790-A5D8-F3A957C2AC6D

Q24617949-765A1B02-4242-4D7F-89EC-F13C1B72277C

Q24617949-82467956-9DD2-4B09-BEB7-E2FD30639CAD

P2860

Q24617949-006B85EB-74B3-40C3-BA80-6B005A384838

Q24617949-114392A3-FCBD-4D9D-A65E-554A70650005

Q24617949-15BAF9E8-EE78-442E-8CA0-21CBA17E134C

Q24617949-22DC3158-1BC4-476F-81EC-9A7FA8738D2A

Q24617949-241EA285-B720-4961-B52D-7AB1D1783CDA

Q24617949-37F845D1-711B-476E-9BAB-8C2A336C6D63

Q24617949-3C44D258-EAFB-45A0-962B-82CDCEECFE78

Q24617949-3DBAB8E3-3450-432B-96A0-DF6BD9A26842

Q24617949-41458ED9-8B9F-421D-9A26-6A7A0B1665BC

Q24617949-42E2D6F0-DAD8-4259-BF64-E8A4D25123D3

P2888

Q24617949-6B17A04E-D29C-4A4B-B37A-C80E7AAE49E2

P304

Q24617949-1D05DE4B-B48A-4298-A0FB-9BC13B38753B

P31

Q24617949-FF00CD11-4478-4D28-A63D-2C4AD8588C26

P3181

Q24617949-B18C10E4-C869-4899-8D0F-FC8708F5F854

P356

Q24617949-B7D36D9E-C777-4EBD-B818-164CAB15D37F

P407

Q24617949-2A31CEBE-15DC-4A0E-B2E1-2680B8A1AE1A

P433

Q24617949-1BE1E3BB-01D5-449F-B0A0-148CD2F05D27

P478

Q24617949-0E92C44A-5D32-486D-B21C-71A9EFB107D8

P50

Q24617949-094BEFD5-31E5-4CCB-893E-E9BE6442F6C8

Q24617949-0EBAC977-9974-41E1-8D50-928512727C0B

Q24617949-103A640D-D503-458F-9BC3-AFD8442A2AED

Q24617949-143F8991-8B00-4912-9946-23DCA77BDAB7

Q24617949-1FFDF47F-9260-4077-9514-164F26D2D356

Q24617949-32A66469-03CF-40A8-94AF-B958E12CE594

Q24617949-506DC269-05D8-4330-94C2-FE47531B332F

Q24617949-53F4E3C9-E4FF-4170-B949-D757CB03BECD

Q24617949-553FDB78-3956-47F0-B4B5-0FAC0B82AD67

Q24617949-6F021CD3-D36C-4A48-BE42-14B84795D5A1

P577

Q24617949-3B67204B-3837-4918-8C24-CC752A1CA0A5

P5875

Q24617949-DDF9C4D9-FC72-4FEE-9E43-98EAD1ACD9F2

P6179

Q24617949-FF189470-7F6F-4BC8-8C71-129D12C8AB37

P698

Q24617949-16098275-BC2C-4393-A6A2-DB281D6B741D

P921

Q24617949-c7c1d9e6-41c5-156b-c4aa-1afa880f86fc

P932

Q24617949-D0CE654D-73E9-45C1-AB91-5CC8AB84C14A

P3181

P356

P1433

P1476

The genomic complexity of primary human prostate cancer

@en

P2093

Alex H Ramos

http://www.w3.org/2001/XMLSchema#string

Andrey Y Sivachenko

http://www.w3.org/2001/XMLSchema#string

Ashutosh Tewari

http://www.w3.org/2001/XMLSchema#string

Dorothee Pflueger

http://www.w3.org/2001/XMLSchema#string

Jane Wilkinson

http://www.w3.org/2001/XMLSchema#string

Jonathan W Simons

http://www.w3.org/2001/XMLSchema#string

Kyung Park

http://www.w3.org/2001/XMLSchema#string

Lukas Habegger

http://www.w3.org/2001/XMLSchema#string

Michael F Berger

http://www.w3.org/2001/XMLSchema#string

Michael S Lawrence

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project

Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2

Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation

An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression

A small-cell lung cancer genome with complex signatures of tobacco exposure

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

Integrative analysis of the melanoma transcriptome

A comprehensive catalogue of somatic mutations from a human cancer genome

Complex landscapes of somatic rearrangement in human breast cancer genomes.

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

P2888

P304

214-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

563283

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NATURE09744

http://www.w3.org/2001/XMLSchema#string

P407

P433

7333

http://www.w3.org/2001/XMLSchema#string

P478

470

http://www.w3.org/2001/XMLSchema#string

P50

Kristian Cibulskis

Lauren Ambrogio

Jennifer Baldwin

P577

2011-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49823637

http://www.w3.org/2001/XMLSchema#string

P6179

1026944448

http://www.w3.org/2001/XMLSchema#string

P698

21307934

http://www.w3.org/2001/XMLSchema#string

P921

prostate cancer

P932

3075885

http://www.w3.org/2001/XMLSchema#string